1-(2-Chloro-3'-fluoro-5-methoxy-[1,1'-biphenyl]-4-yl)-N-(isoxazol-3-yl)-3-methyl-4-oxo-3,4-dihydrophthalazine-6-sulfonamide

ID: ALA4097970

PubChem CID: 117741784

Max Phase: Preclinical

Molecular Formula: C25H18ClFN4O5S

Molecular Weight: 540.96

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc(-c2cccc(F)c2)c(Cl)cc1-c1nn(C)c(=O)c2cc(S(=O)(=O)Nc3ccon3)ccc12

Standard InChI:  InChI=1S/C25H18ClFN4O5S/c1-31-25(32)19-11-16(37(33,34)30-23-8-9-36-29-23)6-7-17(19)24(28-31)20-12-21(26)18(13-22(20)35-2)14-4-3-5-15(27)10-14/h3-13H,1-2H3,(H,29,30)

Standard InChI Key:  HIEJKXMLHXPHRC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   29.3463   -6.8202    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.8221   -6.1560    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   29.0090   -6.0760    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.1026   -4.9379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8148   -5.3385    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.5362   -6.5563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5400   -7.3728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9436   -6.5355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2317   -6.1386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9554   -7.3568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2525   -7.7686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2576   -8.5787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9640   -8.9833    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.6670   -8.5715    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.6635   -7.7552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3680   -7.3412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0775   -7.7489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7816   -7.3356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7757   -6.5176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0599   -6.1146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3588   -6.5303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4797   -6.1026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0813   -8.5661    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.3754   -8.9780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1874   -6.5083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8909   -6.0940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8840   -5.2760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1677   -4.8740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4671   -5.2906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1574   -4.0569    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   34.0508   -5.2975    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   29.0109   -4.1276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2097   -3.9666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8090   -4.6789    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.3627   -5.2799    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.9680   -9.8005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5519   -8.9908    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  5  2  1  0
  2  6  1  0
  6  7  2  0
  7 11  1  0
 10  8  1  0
  8  9  2  0
  9  6  1  0
 10 11  2  0
 10 15  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 19 22  1  0
 17 23  1  0
 23 24  1  0
 22 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 22  1  0
 28 30  1  0
 20 31  1  0
  4 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  1  0
 35  4  2  0
 13 36  1  0
 12 37  2  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

Liver (3974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCN5A Tclin Sodium channel protein type V alpha subunit (3462 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR1I2 Tchem Pregnane X receptor (6667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCN9A Tclin Sodium channel protein type IX alpha subunit (8393 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (4264 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 540.96Molecular Weight (Monoisotopic): 540.0670AlogP: 4.86#Rotatable Bonds: 6
Polar Surface Area: 116.32Molecular Species: ACIDHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 5.73CX Basic pKa: CX LogP: 4.64CX LogD: 3.77
Aromatic Rings: 5Heavy Atoms: 37QED Weighted: 0.33Np Likeness Score: -1.58

References

1. Weiss MM, Dineen TA, Marx IE, Altmann S, Boezio A, Bregman H, Chu-Moyer M, DiMauro EF, Feric Bojic E, Foti RS, Gao H, Graceffa R, Gunaydin H, Guzman-Perez A, Huang H, Huang L, Jarosh M, Kornecook T, Kreiman CR, Ligutti J, La DS, Lin MJ, Liu D, Moyer BD, Nguyen HN, Peterson EA, Rose PE, Taborn K, Youngblood BD, Yu V, Fremeau RT..  (2017)  Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities.,  60  (14): [PMID:28287723] [10.1021/acs.jmedchem.6b01851]

Source